Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelics as a treatment for disorders of consciousness
Gregory Scott, Robin Carhart‐Harris
Neuroscience of Consciousness (2019) Vol. 2019, Iss. 1
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Psychedelics and disorders of consciousness: the current landscape and the path forward
Paolo Cardone, Naji Alnagger, Jitka Annen, et al.
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
G Protein-Coupled Receptors in the Mammalian Blood-Brain Barrier
Brock Pluimer, Mark Colt, Zhen Zhao
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 26
Psychedelics for Brain Injury: A Mini-Review
M. Ijaz Khan, Gregory T. Carter, Sunil Aggarwal, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 22
A scoping review for building a criticality-based conceptual framework of altered states of consciousness
Charles Gervais, Louis-Philippe Boucher, Guillermo Martinez Villar, et al.
Frontiers in Systems Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8
Distributed harmonic patterns of structure-function dependence orchestrate human consciousness
Andrea I. Luppi, Jakub Vohryzek, Morten L. Kringelbach, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 21
The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype
Urszula Kozłowska, Aleksandra Klimczak, Kalina Wiatr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Whole-brain modelling supports the use of serotonergic psychedelics for the treatment of disorders of consciousness
Iván Mindlin, Rubén Herzog, Laouen Belloli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Restoring consciousness with pharmacologic therapy: Mechanisms, targets, and future directions
Megan E. Barra, Ken Solt, Xin Yu, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00374-e00374
Closed Access | Times Cited: 2
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness
Iván Mindlin, Rubén Herzog, Laouen Belloli, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2


Philosophy and the Mind Sciences (2020) Vol. 1, Iss. I
Open Access | Times Cited: 18
Animal Behavior in Psychedelic Research
Anna U. Odland, Jesper L. Kristensen, Jesper T. Andreasen
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 1176-1205
Open Access | Times Cited: 11
Pattern Breaking: A Complex Systems Approach to Psychedelic Medicine
Inês Hipólito, Jonas Mago, Fernando E. Rosas, et al.
(2022)
Open Access | Times Cited: 10
Classic psychedelics do not affect T cell and monocyte immune responses
Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies
Patrick Fissler, Anja Vandersmissen, Marco Filippi, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 679-686
Closed Access | Times Cited: 5
The ethics of psychedelic research in disorders of consciousness
Andrew Peterson, Enzo Tagliazucchi, Charles Weijer
Neuroscience of Consciousness (2019) Vol. 2019, Iss. 1
Open Access | Times Cited: 15
Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives
Ayse Ceren Kaypak, Amir Raz
Transcultural Psychiatry (2022) Vol. 59, Iss. 5, pp. 665-674
Open Access | Times Cited: 8
Therapeutic dissociation: From non-ordinary states to psychological transformation
Joshua Clingo
(2024)
Open Access | Times Cited: 1
A virtual clinical trial of psychedelics to treat patients with disorders of consciousness
Naji Alnagger, Paolo Cardone, Charlotte Martial, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A Pilot Human Study Using Ketamine To Treat Disorders of Consciousness
Paolo Cardone, Arthur Bonhomme, Vincent Bonhomme, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111639-111639
Open Access | Times Cited: 1
Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
Julia Bornemann, James B. Close, Kirran Ahmad, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
A mechanistic model of the neural entropy increase elicited by psychedelic drugs
Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 6
A mechanistic model of the neural entropy increase elicited by psychedelic drugs
Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 8
A single dose of psilocybin induces lasting changes in metabolic connectivity within biologically informed rat brain networks related to compulsions and anxiety.
Frederik Gudmundsen, Julia Czurylo, Camilla Trang Vo, et al.
(2024)
Open Access
Brain health
Vincent Bonhomme, Christian Putensen, Bernd W. Böttiger, et al.
European Journal of Anaesthesiology Intensive Care (2024) Vol. 3, Iss. 6, pp. e0063-e0063
Open Access
Unique biological and physiological properties of endogenous N, N-dimethyltryptamine from the perspective of functioning of the nervous system
J. Schimmelpfennig, Kamila Jankowiak-Siuda
Neuropsychiatria i Neuropsychologia (2023) Vol. 18, Iss. 1-2, pp. 1-10
Open Access | Times Cited: 1

Scroll to top